Monday morning on “TNN Live,” we reported on a rash of adverse reactions in Europe to people who have taken vaccination shots using Moderna, Pfizer, AstraZenca, and Johnson & Johnson shots. Hundreds of thousands of adverse reactions have been reported along with far more deaths from such reactions reported in the U.S. by the CDC. Here’s the story with complete details and numbers:
EudraVigilance, a European database of suspicious drug reaction cases, has reported 8,430 deaths and 354,177 injuries following injections of four experimental Chinese Communist Party (CCP) Virus (COVID-19) shots.
In a statement about their database, EudraVigilance said that their report covers data collected through April 24, 2021, for four experimental vaccines currently in use in Europe from Pfizer, AstraZeneca, Moderna, and Johnson & Johnson:
- COVID-19 MRNA VACCINE MODERNA (CX-024414)
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
- COVID-19 VACCINE JANSSEN (AD26.COV2.S)
4,524 of the 8,430 deaths were reported following Pfizer vaccine injections, and 184,833 of the 354,177 injuries following AstraZeneca vaccine injections, according to EudraVigilance, which monitors reports of accidents and deaths related to the experimental CCP Virus vaccines.
The following is a rundown of the data through April 24:
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/Pfizer: 4,524 deaths and 151,306 injuries
- 11,191 Blood and lymphatic system disorders incl. 40 deaths
- 7,372 Cardiac disorders incl. 522 deaths
- 50 Congenital, familial and genetic disorders incl. Three deaths
- 4,183 Ear and labyrinth disorders incl. Three deaths
- 112 Endocrine disorders
- 4,629 Eye disorders incl. Six deaths
- 33,33 Gastrointestinal disorders incl. 227 deaths
- 103,813General disorders and administration site conditions incl. 1459 deaths
- 214 Hepatobiliary disorders incl. 16 deaths
- 3,338 Immune system disorders incl. 20 deaths
- 10,160 Infections and infestations incl. 527 deaths
- 3,950 Injury, poisoning, and procedural complications incl. 89 deaths
- 7,595 Investigations incl. 168 deaths
- 2,564 Metabolism and nutrition disorders incl. 91 deaths
- 53,714 Musculoskeletal and connective tissue disorders incl. 47 deaths
- 150 Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. Seven deaths
- 65,745 Nervous system disorders incl. 425 deaths
- 192 Pregnancy, puerperium, and perinatal conditions incl. Seven deaths
- 80 Product issues
- 6,008 Psychiatric disorders incl. 63 deaths
- 938 Renal and urinary disorders incl. 66 deaths
- 994 Reproductive system and breast disorders incl. One death
- 13,954 Respiratory, thoracic, and mediastinal disorders incl. 523 deaths
- 16,171 Skin and subcutaneous tissue disorders incl. 35 deaths
- 438 Social circumstances incl. Six deaths
- 124 Surgical and medical procedures incl. Eight deaths
- 8,220 Vascular disorders incl. 165 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 2,283 deaths and 17,625 injuries
- 839 Blood and lymphatic system disorders incl. 16 deaths
- 1,278 Cardiac disorders incl. 231 deaths
- 7 Congenital, familial, and genetic disorders incl. 2 deaths
- 378 Ear and labyrinth disorders
- 23 Endocrine disorders incl. One death
- 570 Eye disorders incl. Three deaths
- 3,857 Gastrointestinal disorders incl. 80 deaths
- 12,513 General disorders and administration site conditions incl. 1012 deaths
- 77 Hepatobiliary disorders incl. Three deaths
- 476 Immune system disorders incl. Three deaths
- 1,449 Infections and infestations incl. 118 deaths
- 803 Injury, poisoning, and procedural complications incl. 44 deaths
- 1,087 Investigations incl. 60 deaths
- 515 Metabolism and nutrition disorders incl. 47 deaths
- 5,669 Musculoskeletal and connective tissue disorders incl. 47 deaths
- 48 Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. Eight deaths
- 7,489 Nervous system disorders incl. 244 deaths
- 50 Pregnancy, puerperium, and perinatal conditions
- 8 Product issues
- 862 Psychiatric disorders incl. 31 deaths
- 299 Renal and urinary disorders incl. 23 deaths
- 106 Reproductive system and breast disorders incl. One death
- 2,198 Respiratory, thoracic, and mediastinal disorders incl. 197 deaths
- 2,163 Skin and subcutaneous tissue disorders incl. 19 deaths
- 162 Social circumstances incl. Six deaths
- 109 Surgical and medical procedures incl. 13 deaths
- 1,166 Vascular disorders incl. 74 deaths
Total reactions for the experimental vaccine AZD1222 (CHADOX1 NCOV-19) from Oxford/AstraZeneca: 1,579 deaths and 184,833 injuries
- 5,319 Blood and lymphatic system disorders incl. 64 deaths
- 7,374 Cardiac disorders incl. 199 deaths
- 76 Congenital, familial and genetic disorders incl. 2 deaths
- 5,011 Ear and labyrinth disorders
- 155 Endocrine disorders incl. 2 deaths
- 7,922 Eye disorders incl. Five deaths
- 56,473 Gastrointestinal disorders incl. 62 deaths
- 141,042General disorders and administration site conditions incl. 495 deaths
- 248 Hepatobiliary disorders incl. 13 deaths
- 1,837 Immune system disorders incl. Seven deaths
- 10,631 Infections and infestations incl. 99 deaths
- 4,341 Injury, poisoning, and procedural complications incl. 18 deaths
- 9,798 Investigations incl. 21 deaths
- 6,977 Metabolism and nutrition disorders incl. 18 deaths
- 82,522 Musculoskeletal and connective tissue disorders incl. 16 deaths
- 144 Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. 4 deaths
- 111,873Nervous system disorders incl. 244 deaths
- 108 Pregnancy, puerperium, and perinatal conditions
- 52 Product issues
- 9,514 Psychiatric disorders incl. 12 deaths
- 1,745 Renal and urinary disorders incl. 11 deaths
- 2,076 Reproductive system and breast disorders
- 15,824 Respiratory, thoracic, and mediastinal disorders incl. 171 deaths
- 23,168 Skin and subcutaneous tissue disorders incl. 10 deaths
- 364 Social circumstances incl. Three deaths
- 383 Surgical and medical procedures incl. 12 deaths
- 8,706 Vascular disorders incl. 91 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 44 deaths and 413 injuries
- 11 Blood and lymphatic system disorders
- 45 Cardiac disorders incl. 10 deaths
- 1 Congenital, a familial and genetic disorder
- 20 Ear and labyrinth disorders
- 1 Endocrine disorder
- 20 Eye disorders
- 109 Gastrointestinal disorders incl. One death
- 235 General disorders and administration site conditions incl. 14 deaths
- 3 Hepatobiliary disorders
- 18 Immune system disorders
- 44 Infections and infestations incl. 2 deaths
- 34 Injury, poisoning, and procedural complications incl. One death
- 61 Investigations
- 19 Metabolism and nutrition disorders incl. One death
- 95 Musculoskeletal and connective tissue disorders incl. One death
- 232 Nervous system disorders incl. Three deaths
- 3 Product issues
- 45 Psychiatric disorders
- 11 Renal and urinary disorders
- 5 Reproductive system and breast disorders
- 80 Respiratory, thoracic, and mediastinal disorders incl. Three deaths
- 50 Skin and subcutaneous tissue disorders
- 5 Social circumstances
- 3 Surgical and medical procedures
- 96 Vascular disorders incl. Eight deaths
This data is provided by the European Medicines Agency (EMA), and anybody can check it using the EudraVigilance framework.
The use of AstraZeneca’s experimental CCP Virus shots has been effectively halted in Denmark and Norway.
According to a Norwegian Institute of Public Health statement, the AstraZeneca COVID-19 “vaccine” is riskier than the virus itself, particularly for young people.
